These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7487383)

  • 1. Responsibilities in point-of-care testing. An institutional perspective.
    Lamb LS
    Arch Pathol Lab Med; 1995 Oct; 119(10):886-9. PubMed ID: 7487383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current nursing practice of point-of-care laboratory diagnostic testing in critical care units.
    Lamb LS; Parrish RS; Goran SF; Biel MH
    Am J Crit Care; 1995 Nov; 4(6):429-34. PubMed ID: 8556083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a robotic near patient testing laboratory.
    Felder RA; Savory J; Margrey KS; Holman JW; Boyd JC
    Arch Pathol Lab Med; 1995 Oct; 119(10):948-51. PubMed ID: 7487397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automated approaches to rapid-response testing. A comparative evaluation of point-of-care and centralized laboratory testing.
    Fleisher M; Schwartz MK
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S18-25. PubMed ID: 7484944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point-of-care testing in the intensive care unit. The intensive care physician's perspective.
    Castro HJ; Oropello JM; Halpern N
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S95-9. PubMed ID: 7484955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful alternatives to alternate site testing. Use of a pneumatic tube system to the central laboratory.
    Green M
    Arch Pathol Lab Med; 1995 Oct; 119(10):943-7. PubMed ID: 7487396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interinstitutional comparison of bedside blood glucose monitoring program characteristics, accuracy performance, and quality control documentation: a College of American Pathologists Q-Probes study of bedside blood glucose monitoring performed in 226 small hospitals.
    Novis DA; Jones BA
    Arch Pathol Lab Med; 1998 Jun; 122(6):495-502. PubMed ID: 9625416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementing a point-of-care testing program in the critical care setting.
    Giuliano KK; Perkins S
    Clin Leadersh Manag Rev; 2002; 16(3):139-47. PubMed ID: 12046267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the medical need for alternate site testing. A clinician's perspective.
    Becker RC
    Arch Pathol Lab Med; 1995 Oct; 119(10):894-7. PubMed ID: 7487385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. College of American Pathologists Conference XXVIII on alternate site testing: introduction.
    Handorf CR
    Arch Pathol Lab Med; 1995 Oct; 119(10):867-73. PubMed ID: 7487378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost analysis for decision support: the case of comparing centralized versus distributed methods for blood gas testing.
    Kilgore ML; Steindel SJ; Smith JA
    J Healthc Manag; 1999; 44(3):207-15. PubMed ID: 10537498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mobile laboratory in alternative site testing.
    Fuhrman SA; Travers EM; Handorf CR
    Arch Pathol Lab Med; 1995 Oct; 119(10):939-42. PubMed ID: 7487395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. College of American Pathologists Conference XXVIII on alternate site testing. What must we now do?
    Howanitz PJ
    Arch Pathol Lab Med; 1995 Oct; 119(10):979-83. PubMed ID: 7487399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turnaround times in the laboratory: a review of the literature.
    Manor PG
    Clin Lab Sci; 1999; 12(2):85-9. PubMed ID: 10387493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The virtual laboratory: regional clinical diagnostics for integrated delivery systems.
    Steiner JW
    Healthc Financ Manage; 1997 Nov; 51(11):40, 42-4. PubMed ID: 10174769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guidelines for point-of-care testing. Improving patient outcomes.
    Kost GJ
    Am J Clin Pathol; 1995 Oct; 104(4 Suppl 1):S111-27. PubMed ID: 7484942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood gas/pH analyzers.
    Health Devices; 1995; 24(5-6):208-43. PubMed ID: 7591807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Financial justification of alternate site testing.
    De Cresce RP; Phillips DL; Howanitz PJ
    Arch Pathol Lab Med; 1995 Oct; 119(10):898-901. PubMed ID: 7487386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternate site testing. The old and new paradigm or the past is prologue.
    Bachner P
    Arch Pathol Lab Med; 1995 Oct; 119(10):881-5. PubMed ID: 7487382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point-of-care testing versus central lab costs.
    Baer DM
    MLO Med Lab Obs; 1998 Sep; 30(9):46-8, 50-2, 54-6. PubMed ID: 10186317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.